Anna Protopapas

Director at Nuvalent · 7 reported transactions in 2 companies · latest report Jul 15, 2026

Their trades


NuvalentNUVL	Returned to company — · 3,444 shares	Jul 15, 2026
NuvalentNUVL	Other $638.1K · 5,146 shares	Jul 15, 2026
NuvalentNUVL	Share award — · 3,444 shares	Jun 16, 2026
Mersana TherapeuticsMRSN	Other — · 9,609 shares	Jan 6, 2026
Mersana TherapeuticsMRSN	Other — · 2,890 shares	Jan 6, 2026
Mersana TherapeuticsMRSN	Other — · 6,721 shares	Jan 6, 2026
NuvalentNUVL	Share award — · 2,647 shares	Jun 18, 2025

Returned to companyNuvalent

Jul 15, 2026 · NUVL

3,444

OtherNuvalent

Jul 15, 2026 · NUVL

$638.1K

Share awardNuvalent

Jun 16, 2026 · NUVL

3,444

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

9,609

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

2,890

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

6,721

Share awardNuvalent

Jun 18, 2025 · NUVL

2,647

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

← Back

Anna Protopapas

Director at Nuvalent · 7 reported transactions in 2 companies · latest report Jul 15, 2026

Their trades


NuvalentNUVL	Returned to company — · 3,444 shares	Jul 15, 2026
NuvalentNUVL	Other $638.1K · 5,146 shares	Jul 15, 2026
NuvalentNUVL	Share award — · 3,444 shares	Jun 16, 2026
Mersana TherapeuticsMRSN	Other — · 9,609 shares	Jan 6, 2026
Mersana TherapeuticsMRSN	Other — · 2,890 shares	Jan 6, 2026
Mersana TherapeuticsMRSN	Other — · 6,721 shares	Jan 6, 2026
NuvalentNUVL	Share award — · 2,647 shares	Jun 18, 2025

Returned to companyNuvalent

Jul 15, 2026 · NUVL

3,444

OtherNuvalent

Jul 15, 2026 · NUVL

$638.1K

Share awardNuvalent

Jun 16, 2026 · NUVL

3,444

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

9,609

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

2,890

OtherMersana Therapeutics

Jan 6, 2026 · MRSN

6,721

Share awardNuvalent

Jun 18, 2025 · NUVL

2,647

7 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Their trades

Others trading the same companies

Their trades

Others trading the same companies